Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression

Benjamin Le Calvé, Michal Rynkowski, Marie Le Mercier, Céline Bruyère, Caroline Lonez, Thierry Gras, Benjamin Haibe-Kains, Gianluca Bontempi, Christine Decaestecker, Jean-Marie Ruysschaert, Robert Kiss, Florence Lefranc

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology